Pregnant mums taking miscarriage prevention drug decades ago may have put...
A new study reveals that a drug that was taken by millions of pregnant women decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other...
View ArticleVitamin D deficiency may account for unexplained disparities in cancer...
A paper just published in Dermato-Endocrinology suggests that vitamin D deficiency may account for unexplained disparities in cancer survival rates between African and White Americans.
View ArticleStudy to determine prevalence of abnormal anal cytology and HPV in at-risk women
A basic connection of statistics lead a researcher at Women & Infants Hospital of Rhode Island to question whether women should be screened for anal cancer during a regular visit to the...
View ArticleCall for long follow-up after CIN3 treatment
Researchers from Sweden say that women who have been treated for cervical precancer should receive lifelong follow-up, after finding that their risk for dying from vaginal or cervical cancer markedly...
View ArticleHigh-volume medical centers improve gynecologic cancer survival
Women with ovarian and other gynecologic cancers live significantly longer when they receive care at hospitals that treat a large number of patients with these conditions, according to research on more...
View ArticleScientists report first human recipients of laboratory-grown vaginal organs
Scientists reported today the first human recipients of laboratory-grown vaginal organs. A research team led by Anthony Atala, M.D., director of Wake Forest Baptist Medical Center's Institute for...
View ArticleJapanese mushroom extract shows promise in eradicating HPV
A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus (HPV), according to a pilot clinical trial at The University of Texas Health Science Center at Houston...
View ArticleHPV vaccine does not increase rates of STIs in adolescent females
Receiving the human papillomavirus vaccine does not increase rates of sexually transmitted infections (STIs) in adolescent females. The vaccine, which can prevent cervical cancer in women, has had a...
View ArticleMerck announces availability of GARDASIL 9 HPV vaccine in Canada
Merck, known as MSD outside the United States and Canada, announced today that GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merck's 9-valent human papillomavirus (HPV) vaccine, is...
View ArticleStudy shows women with CIN3 more likely to develop anogenital cancers
Women with a history of severe cervical intraepithelial neoplasia, a precancerous condition of the cervix that arises from infection with the human papillomavirus (HPV), had a long-term increased risk...
View ArticleCall for long follow-up after CIN3 treatment
Researchers from Sweden say that women who have been treated for cervical precancer should receive lifelong follow-up, after finding that their risk for dying from vaginal or cervical cancer markedly...
View ArticleHigh-volume medical centers improve gynecologic cancer survival
Women with ovarian and other gynecologic cancers live significantly longer when they receive care at hospitals that treat a large number of patients with these conditions, according to research on more...
View ArticleScientists report first human recipients of laboratory-grown vaginal organs
Scientists reported today the first human recipients of laboratory-grown vaginal organs. A research team led by Anthony Atala, M.D., director of Wake Forest Baptist Medical Center's Institute for...
View ArticleJapanese mushroom extract shows promise in eradicating HPV
A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus (HPV), according to a pilot clinical trial at The University of Texas Health Science Center at Houston...
View ArticleHPV vaccine does not increase rates of STIs in adolescent females
Receiving the human papillomavirus vaccine does not increase rates of sexually transmitted infections (STIs) in adolescent females. The vaccine, which can prevent cervical cancer in women, has had a...
View ArticleMerck announces availability of GARDASIL 9 HPV vaccine in Canada
Merck, known as MSD outside the United States and Canada, announced today that GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merck's 9-valent human papillomavirus (HPV) vaccine, is...
View ArticleStudy shows women with CIN3 more likely to develop anogenital cancers
Women with a history of severe cervical intraepithelial neoplasia, a precancerous condition of the cervix that arises from infection with the human papillomavirus (HPV), had a long-term increased risk...
View ArticleNewest vaccine highly effective at preventing nine types of HPV infection,...
Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations.
View Article
More Pages to Explore .....